Literature DB >> 34629708

Radiation Lobectomy: An Overview of Concept and Applications, Technical Considerations, Outcomes.

Pouya Entezari1, Ahmed Gabr1, Kristie Kennedy1, Riad Salem1,2, Robert J Lewandowski1,2.   

Abstract

Surgical resection has long been considered curative for patients with early-stage hepatocellular carcinoma (HCC). However, inadequate future liver remnant (FLR) renders many patients not amenable to surgery. Recently, lobar administration of yttrium-90 (Y90) radioembolization has been utilized to induce FLR hypertrophy while providing disease control, eventually facilitating resection in patients with hepatic malignancy. This has been termed "radiation lobectomy (RL)." The concept is evolving, with modified approaches combining RL and high-dose curative-intent radioembolization (radiation segmentectomy) to achieve tumor ablation. This article provides an overview of the concept and applications of RL, including technical considerations and outcomes in patients with hepatic malignancies. Thieme. All rights reserved.

Entities:  

Keywords:  future liver remnant; hepatocellular carcinoma; interventional radiology; radiation lobectomy; radioembolization

Year:  2021        PMID: 34629708      PMCID: PMC8497080          DOI: 10.1055/s-0041-1735530

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.780


  42 in total

Review 1.  Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care.

Authors:  David C Madoff; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  J Vasc Interv Radiol       Date:  2005-06       Impact factor: 3.464

2.  Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations.

Authors:  Seza A Gulec; Geraldine Mesoloras; Michael Stabin
Journal:  J Nucl Med       Date:  2006-07       Impact factor: 10.057

3.  Neoadjuvant transarterial radiation lobectomy for colorectal hepatic metastases: a small cohort analysis on safety, efficacy, and radiopathologic correlation.

Authors:  Jehan L Shah; Ivan R Zendejas-Ruiz; Linday M Thornton; Brian S Geller; Joseph R Grajo; Amy Collinsworth; Thomas J George; Beau Toskich
Journal:  J Gastrointest Oncol       Date:  2017-06

4.  Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization.

Authors:  N Kokudo; K Tada; M Seki; H Ohta; K Azekura; M Ueno; K Ohta; T Yamaguchi; T Matsubara; T Takahashi; T Nakajima; T Muto; T Ikari; A Yanagisawa; Y Kato
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

Authors:  S Ho; W Y Lau; T W Leung; M Chan; Y K Ngar; P J Johnson; A K Li
Journal:  Eur J Nucl Med       Date:  1996-08

6.  Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres.

Authors:  T F Jakobs; S Saleem; B Atassi; E Reda; R J Lewandowski; V Yaghmai; F Miller; R K Ryu; S Ibrahim; K T Sato; L M Kulik; M F Mulcahy; R Omary; R Murthy; M F Reiser; R Salem
Journal:  Dig Dis Sci       Date:  2008-01-31       Impact factor: 3.199

Review 7.  A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Authors:  Jin-Yao Teo; John C Allen; David C Ng; Su-Pin Choo; David W M Tai; Jason P E Chang; Foong-Khoon Cheah; Pierce K H Chow; Brian K P Goh
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

Review 8.  Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Am J Surg       Date:  2008-04-23       Impact factor: 2.565

Review 9.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

10.  Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.

Authors:  Xavier Palard; Julien Edeline; Yan Rolland; Samuel Le Sourd; Marc Pracht; Sophie Laffont; Laurence Lenoir; Karim Boudjema; Thomas Ugen; Vanessa Brun; Habiba Mesbah; Laure-Anne Haumont; Pascal Loyer; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-25       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.